JPMorgan raised the firm’s price target on Novonesis (NVZMY) to DKK 545 from DKK 520 and keeps an Overweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVZMY: